Vicat : Back towards the lower end of the range
Entry price | Target | Stop-loss | Potential |
---|
€43.45 |
€46 |
€42.1 |
+5.87% |
---|
After having been stuck in a trading range, shares in Vicat are returning to the lower bound of the range phase. This appears to be a good opportunity for opening new positions.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● In a short-term perspective, the company has interesting fundamentals.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 40.8, which offers good timing for buyers.
● With a P/E ratio at 11.97 for the current year and 10.69 for next year, earnings multiples are highly attractive compared with competitors.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● The company's earnings releases usually do not meet expectations.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.